GB201709331D0 - Therapeutic multispecific targeting molecules - Google Patents
Therapeutic multispecific targeting moleculesInfo
- Publication number
- GB201709331D0 GB201709331D0 GBGB1709331.1A GB201709331A GB201709331D0 GB 201709331 D0 GB201709331 D0 GB 201709331D0 GB 201709331 A GB201709331 A GB 201709331A GB 201709331 D0 GB201709331 D0 GB 201709331D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- targeting molecules
- multispecific targeting
- therapeutic multispecific
- therapeutic
- molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1709331.1A GB201709331D0 (en) | 2017-06-12 | 2017-06-12 | Therapeutic multispecific targeting molecules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1709331.1A GB201709331D0 (en) | 2017-06-12 | 2017-06-12 | Therapeutic multispecific targeting molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201709331D0 true GB201709331D0 (en) | 2017-07-26 |
Family
ID=59358178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1709331.1A Ceased GB201709331D0 (en) | 2017-06-12 | 2017-06-12 | Therapeutic multispecific targeting molecules |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201709331D0 (en) |
-
2017
- 2017-06-12 GB GBGB1709331.1A patent/GB201709331D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL259017A (en) | Targeted cancer therapy | |
IL268894A (en) | Therapeutic rna | |
SG10201913631TA (en) | Rna for cancer therapy | |
IL254705B (en) | Combination therapy for cancer | |
IL277261A (en) | Small molecules against cancer | |
GB201500463D0 (en) | Therapeutic molecules | |
GB201500461D0 (en) | Therapeutic molecules | |
GB201512365D0 (en) | Novel therapy | |
IL253549B (en) | Antibody-urease conjugates for therapeutic purposes | |
ZA202001649B (en) | Rna molecules | |
ZA201701450B (en) | Small molecule inhibitors for cancer therapy | |
EP3423581A4 (en) | Targeting microrna for cancer treatment | |
GB201519734D0 (en) | Cancer therapy | |
GB201505382D0 (en) | Novel therapy | |
HK1254687A1 (en) | Combination therapy for cancer | |
GB201709331D0 (en) | Therapeutic multispecific targeting molecules | |
GB201516068D0 (en) | Novel therapy | |
HRP20210383T8 (en) | Combination therapy for cancer | |
GB201600559D0 (en) | Therapeutic molecules | |
GB201710109D0 (en) | Albumin-based therapeutic molecules | |
GB201710105D0 (en) | Albumin-based therapeutic molecules | |
IL252360B (en) | Sugar-dipeptide conjugates as flavor molecules | |
IL252359A0 (en) | Sugar-dipeptide conjugates as flavor molecules | |
EP3338779A4 (en) | Tumor therapeutic agent | |
GB201511609D0 (en) | Cancer therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |